Moderna Inc (MRNA) Down 0.67% in Premarket Trading

Moderna Inc (MRNA) has fallen Wednesday morning, with the stock declining -0.67% in pre-market trading to 121.41. MRNA's short-term technical score of 29 indicates that the stock has traded less bullishly over the last month than 71% of stocks on the market. In the Biotechnology industry, which ranks 125 out of 146 industries, Moderna Inc ranks higher than 40% of stocks. Moderna Inc has fallen 10.59% over the past month, closing at $132.27 on August 31. During this period of time, the stock fell as low as $119.69 and as high as $144.79. MRNA has an average analyst recommendation of Buy. The company has an average price target of $230.42.

MRNA has an Overall Score of 65. Find out what this means to you and get the rest of the rankings on MRNA!

See Full MRNA Report

Moderna Inc has a Long-Term Technical rank of 67. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 33% of the market scoring higher. In the Biotechnology industry which is number 52 by this metric, MRNA ranks better than 52% of stocks.

Important Dates for Investors in MRNA:

-Moderna Inc is set to release earnings on 11/3/2022. Over the last 12 months, the company has reported EPS of $32.81. -We do not have a set dividend date for Moderna Inc at this time. Click Here To Get The Full Report on Moderna Inc (MRNA)